四君子汤合五苓散在肝硬化腹水治疗中的价值分析

打开文本图片集

【摘要】目的：分析对肝硬化腹水患者予以四君子汤合五苓散治疗的价值。方法：分析对象选择于2020年12月—2022年12月就诊于我院的肝硬化腹水患者53例，随机方法分组分析，27例予以四君子汤合五苓散治疗的患者纳入试验组，26例予以西药治疗者纳入对照组，对比和分析治疗效果。结果：与对照组比较，试验组患者治疗有效率明显较高（P

【关键词】肝硬化腹水；四君子汤；五苓散；肝功能

Value analysis of Sijunzi Decoction and Wuling Powder in ascites of cirrhosis

LIU Lina

The First People’s Hospital of Longxi County， Gansu Province， Dingxi， Gansu 748100， China

【Abstract】Objective： To analyze the therapeutic value of Sijunzi Decoction combined with Wuling SAN for patients with ascites of cirrhosis. Methods： 53 patients with ascites of cirrhosis admitted to our hospital from December 2020 to December 2022 were selected for random grouping analysis. 27 patients treated with Sijunzi Decoction combined with Wuling SAN were included in the experimental group， and 26 patients treated with western medicine were included in the control group. The therapeutic effects were compared and analyzed. Results： Compared with the control group， the treatment effective rate of experimental group was significantly higher（P

【Key Words】Ascites of cirrhosis； Sijunzi Decoction； Wuling Powder； Liver function

肝硬化在临床上作为一种常见的肝脏疾病，伴随病情进展极易导致各种并发症发生，其中肝硬化腹水为一种严重并发症，其致病原因复杂、多样，呈现弥漫性、进行性、慢性[1]。（剩余4126字）